glp 1 agonist anti inflammatory GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Anti-inflammatory Pathways of Novel Anti-diabetic

10,11 REFERENCES 1

A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity

N., et al., Changes in Body Fat and Weight After a Breast Cancer Diagnosis: Influence of Demographic, Prognostic, and Lifestyle Factors, Journal of Clinical Oncology 23 (2005): 774782

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

However, triple receptor agonism, or agonism/antagonism combinations, can be achieved not only though unimolecular triple agonists, but also by combining mono- and dual-agonists